Business

CVS unit settles with US for $5.25m

WASHINGTON — The Department of Justice said Monday that a unit of CVS Caremark Corp. has agreed to pay $5.25 million to settle allegations that it reported false information on prescription drug prices to the government’s Medicare program.

Federal investigators said the company’s RxAmerica subsidiary reported false information about the prices of generic prescription drugs between 2007 and 2008. The Centers for Medicare and Medicaid Services used this information in a website called Plan Finder, which seniors could use to estimate their out-of-pocket drug expenses. But Department of Justice officials said the actual drug prices offered by the company were ‘‘in some cases significantly higher’’ than those submitted for use on the website.

Advertisement

‘‘Those navigating our Medicare system deserve accurate information so they can make informed choices and obtain the benefits to which they are entitled,’’ said Loretta Lynch, US attorney for the Eastern District of New York.

Since 2006 Medicare has included coverage for prescription drugs, though the actual plans are administered by private pharmacy benefit managers like CVS and Express Scripts.

Get Business Headlines in your inbox:
The Globe's latest business headlines delivered every morning, Monday through Friday.
Thank you for signing up! Sign up for more newsletters here

The civil settlement resolves allegations made in two separate whistle-blower lawsuits against Woonsocket, R.I.-based CVS in 2008 and 2009.

CVS said it agreed to the settlement to avoid protracted and expensive litigation. It noted the period in question came before it acquired RxAmerica through its takeover of Longs Drugs Stores.

Associated Press

Loading comments...
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com
Already a subscriber?
Your city. Your stories. Your Globe.
Yours FREE for two weeks.
Enjoy free unlimited access to Globe.com for the next two weeks.
Limited time only - No credit card required!
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.
Thanks & Welcome to Globe.com
You now have unlimited access for the next two weeks.
BostonGlobe.com complimentary digital access has been provided to you, without a subscription, for free starting today and ending in 14 days. After the free trial period, your free BostonGlobe.com digital access will stop immediately unless you sign up for BostonGlobe.com digital subscription. Current print and digital subscribers are not eligible for the free trial.